NO305559B1 - Substituerte bifenyl-sulfonamid-endotelin-antagonister - Google Patents

Substituerte bifenyl-sulfonamid-endotelin-antagonister

Info

Publication number: NO305559B1
Authority: NO; Norway
Prior art keywords: biphenylsulfonamide; substituted; endothelin antagonists; endothelin; antagonists
Prior art date: 1995-02-06

Application number

NO960473A

Other languages

English (en)

Norwegian (no)

Other versions

NO960473L (no

NO960473D0 (no

Inventor

Natesan Murugesan

Joel C Barrish

Philip D Stein

Original Assignee

Bristol Myers Squibb Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-02-06

Filing date

1996-02-05

Publication date

1999-06-21

1995-02-06 Priority claimed from US08/384,066 external-priority patent/US5760038A/en

1996-02-05 Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co

1996-02-05 Publication of NO960473D0 publication Critical patent/NO960473D0/no

1996-08-07 Publication of NO960473L publication Critical patent/NO960473L/no

1999-06-21 Publication of NO305559B1 publication Critical patent/NO305559B1/no

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Cardiology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Heart & Thoracic Surgery (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Plural Heterocyclic Compounds (AREA)

NO960473A 1995-02-06 1996-02-05 Substituerte bifenyl-sulfonamid-endotelin-antagonister NO305559B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US08/384,066 US5760038A (en)	1995-02-06	1995-02-06	Substituted biphenyl sulfonamide endothelin antagonists
SG1996000999A SG46218A1 (en)	1995-02-06	1996-02-06	Substituted biphenyl sulfonamide endothelin antagonists

Publications (3)

Publication Number	Publication Date
NO960473D0 NO960473D0 (no)	1996-02-05
NO960473L NO960473L (no)	1996-08-07
NO305559B1 true NO305559B1 (no)	1999-06-21

Family

ID=26665074

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO960473A NO305559B1 (no)	1995-02-06	1996-02-05	Substituerte bifenyl-sulfonamid-endotelin-antagonister

Country Status (11)

Country	Link
EP (1)	EP0725067A1 (pl)
JP (1)	JPH08245600A (pl)
CN (1)	CN1060172C (pl)
CA (1)	CA2168154A1 (pl)
CZ (1)	CZ29296A3 (pl)
FI (1)	FI960516L (pl)
HU (1)	HUP9600256A3 (pl)
IL (1)	IL116916A (pl)
NO (1)	NO305559B1 (pl)
PL (1)	PL183283B1 (pl)
SG (1)	SG46218A1 (pl)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5962490A (en)	1987-09-25	1999-10-05	Texas Biotechnology Corporation	Thienyl-, furyl- and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
US6342610B2 (en)	1993-05-20	2002-01-29	Texas Biotechnology Corp.	N-aryl thienyl-, furyl-, and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
US6541498B2 (en)	1993-05-20	2003-04-01	Texas Biotechnology	Benzenesulfonamides and the use thereof to modulate the activity of endothelin
US6613804B2 (en)	1993-05-20	2003-09-02	Encysive Pharmaceuticals, Inc.	Biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin
US6376523B1 (en)	1994-05-20	2002-04-23	Texas Biotechnology Corporation	Benzenesulfonamides and the use thereof to modulate the activity of endothelin
US6030991A (en) *	1993-05-20	2000-02-29	Texas Biotechnology Corp.	Benzenesulfonamides and the use thereof to modulate the activity of endothelin
US5612359A (en) *	1994-08-26	1997-03-18	Bristol-Myers Squibb Company	Substituted biphenyl isoxazole sulfonamides
EP0819125B1 (en) *	1995-04-04	2003-06-18	Texas Biotechnology Corporation	Thienyl-, furyl-, pyrrolyl- and biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin
US5846990A (en) *	1995-07-24	1998-12-08	Bristol-Myers Squibb Co.	Substituted biphenyl isoxazole sulfonamides
JPH09124620A (ja) *	1995-10-11	1997-05-13	Bristol Myers Squibb Co	置換ビフェニルスルホンアミドエンドセリン拮抗剤
AU717230B2 (en)	1996-02-20	2000-03-23	Bristol-Myers Squibb Company	Methods for the preparation of biphenyl isoxazole sulfonamides
US5856507A (en) *	1997-01-21	1999-01-05	Bristol-Myers Squibb Co.	Methods for the preparation of biphenyl isoxazole sulfonamides
US5939446A (en) *	1996-04-09	1999-08-17	Bristol-Myers Squibb Co.	Heteroaryl substituted phenyl isoxazole sulfonamide endothelin antagonists
US5804585A (en) *	1996-04-15	1998-09-08	Texas Biotechnology Corporation	Thieno-pyridine sulfonamides derivatives thereof and related compounds that modulate the activity of endothelin
WO1998033781A1 (en) *	1997-01-30	1998-08-06	Bristol-Myers Squibb Company	Method for preventing or treating low renin hypertension by administering an endothelin antagonist
TW536540B (en) *	1997-01-30	2003-06-11	Bristol Myers Squibb Co	Endothelin antagonists: N-[[2'-[[(4,5-dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]-2-yl]methyl]-N,3,3-trimethylbutanamide and N-(4,5-dimethyl-3-isoxazolyl)-2'-[(3,3-dimethyl-2-oxo-1-pyrrolidinyl)methyl]-4'-(2-oxazolyl)[1,1'-biphe
US6030975A (en) *	1997-03-14	2000-02-29	Basf Aktiengesellschaft	Carboxylic acid derivatives, their preparation and use in treating cancer
US5783705A (en)	1997-04-28	1998-07-21	Texas Biotechnology Corporation	Process of preparing alkali metal salys of hydrophobic sulfonamides
TR200202738T2 (tr)	1997-04-28	2003-03-21	Texas Biotechnology Corporation	Endotelin ile ilgili hastalıkların tedavisinde kullanılan sülfanoamidler
CA2326427A1 (en) *	1998-03-31	1999-10-07	Koichiro Yamada	Preventives/remedies for urinary disorder
ID26984A (id) *	1998-07-06	2001-02-22	Bristol Myers Squibb Co	Senyawa-senyawa sulfonamida sebagai antagonis reseptor angiotensin endotelin ganda
CA2367916A1 (en)	1999-03-19	2000-09-28	Ambarish Singh	Methods for the preparation of biphenyl isoxazole sulfonamides
US6455554B1 (en)	1999-06-07	2002-09-24	Targacept, Inc.	Oxopyridinyl pharmaceutical compositions and methods for use
US6639082B2 (en)	2000-10-17	2003-10-28	Bristol-Myers Squibb Company	Methods for the preparation of biphenyl isoxazole sulfonamides
JP6139272B2 (ja) *	2012-06-01	2017-05-31	株式会社半導体エネルギー研究所	発光素子の作製方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5591761A (en) *	1993-05-20	1997-01-07	Texas Biotechnology Corporation	Thiophenyl-, furyl-and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
NZ247440A (en) *	1992-05-06	1995-04-27	Squibb & Sons Inc	Phenyl sulphonamide derivatives, preparation and pharmaceutical compositions thereof

1996
- 1996-01-26 IL IL11691696A patent/IL116916A/xx not_active IP Right Cessation
- 1996-01-26 CA CA002168154A patent/CA2168154A1/en not_active Abandoned
- 1996-01-31 CZ CZ96292A patent/CZ29296A3/cs unknown
- 1996-02-05 NO NO960473A patent/NO305559B1/no not_active IP Right Cessation
- 1996-02-05 HU HU9600256A patent/HUP9600256A3/hu unknown
- 1996-02-05 FI FI960516A patent/FI960516L/fi unknown
- 1996-02-06 SG SG1996000999A patent/SG46218A1/en unknown
- 1996-02-06 PL PL96312650A patent/PL183283B1/pl unknown
- 1996-02-06 EP EP96101685A patent/EP0725067A1/en not_active Withdrawn
- 1996-02-06 JP JP8019792A patent/JPH08245600A/ja active Pending
- 1996-02-06 CN CN96102541A patent/CN1060172C/zh not_active Expired - Fee Related

Also Published As

Publication number	Publication date
PL312650A1 (en)	1996-08-19
HU9600256D0 (en)	1996-03-28
FI960516A7 (fi)	1996-08-07
SG46218A1 (en)	1998-02-20
PL183283B1 (pl)	2002-06-28
CN1138581A (zh)	1996-12-25
IL116916A0 (en)	1996-05-14
CZ29296A3 (en)	1996-09-11
NO960473L (no)	1996-08-07
CN1060172C (zh)	2001-01-03
JPH08245600A (ja)	1996-09-24
HUP9600256A3 (en)	1998-08-28
EP0725067A1 (en)	1996-08-07
NO960473D0 (no)	1996-02-05
IL116916A (en)	2000-09-28
CA2168154A1 (en)	1996-08-07
FI960516A0 (fi)	1996-02-05
FI960516L (fi)	1996-08-07
HUP9600256A2 (en)	1997-10-28

Legal Events

Date	Code	Title	Description
2002-09-30	MM1K	Lapsed by not paying the annual fees	Free format text: LAPSED IN AUGUST 2002

Publication	Publication Date	Title
FI961804A0 (fi)	1996-04-26	Endoteliinireseptoriantagonistit
FI960953A7 (fi)	1996-09-19	Endoteliinireseptoriantagonisteja
FI960516A0 (fi)	1996-02-05	Substituoituja bifenyylisulfonamidiendoteliiniantagonisteja
NO943190L (no)	1995-03-01	Sulfonamid-endothelin-antagonister
EP0986385A4 (en)	2001-05-16	GONADORELIN ANTAGONISTS
DE69327720D1 (de)	2000-03-02	Endothelin rezeptor antagonisten
BR9609320A (pt)	1999-07-06	Cianofeniluracilas substituidas
DK0699069T3 (da)	2002-05-27	Endothelinreceptorantagonister
NO20000542L (no)	2000-04-04	Endothelin-antagonister
BR9507220A (pt)	1997-09-09	Antagonistas de receptores de endotelina
DE69636597D1 (de)	2006-11-16	Endothelin rezeptor antagonisten
BR9609319A (pt)	1999-07-06	Carbonilaminofeniluracilas substituídas
NO963131D0 (no)	1996-07-26	Endotelinreseptorantagonister
BR9608890A (pt)	1999-06-15	N-metilenotiouréias substituídas
DE69626986D1 (de)	2003-04-30	Endothelinrezeptorantagonist
NO963213D0 (no)	1996-08-01	Endotelinreseptorantagonister
FI944905A7 (fi)	1994-10-19	Endoteliiniantagonistit II
BR9603432A (pt)	1998-05-12	Antagonistas de receptores de endotelina
BR9603376A (pt)	1998-05-12	Tetrahidro-5-nitro-pirimidinas substituídas
DE69628924D1 (de)	2003-08-07	Endothelinrezeptorantagonisten
DE59607958D1 (de)	2001-11-22	Substituierte phenyluracile